Intellia Therapeutics, Inc.

Bank of New York Mellon Corp NTLA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

314,202

Value ($000)

2,825

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	2,825	0.0%	314,202	12/31/2025
2025 Q3	11/3/2025	5,406	0.0%	313,050	9/30/2025
2025 Q2	8/5/2025	2,919	0.0%	311,168	6/30/2025
2025 Q1	4/29/2025	2,005	0.0%	281,943	3/31/2025
2024 Q4	2/4/2025	3,319	0.0%	284,614	12/31/2024
2024 Q3	11/12/2024	5,925	0.0%	288,344	9/30/2024
2024 Q2	7/25/2024	8,153	0.0%	364,306	6/30/2024
2024 Q1	4/25/2024	9,959	0.0%	362,005	3/31/2024
2023 Q4	1/29/2024	12,001	0.0%	393,595	12/31/2023
2023 Q3	10/24/2023	12,637	0.0%	399,653	9/30/2023
2023 Q2	8/3/2023	16,273	0.0%	399,046	6/30/2023
2023 Q1	5/9/2023	13,713	0.0%	367,938	3/31/2023
2022 Q4	2/14/2023	13,215	0.0%	378,750	12/31/2022
2022 Q3	11/14/2022	19,135	0.0%	341,947	9/30/2022
2022 Q2	8/15/2022	15,514	0.0%	299,739	6/30/2022
2022 Q1	5/11/2022	21,407	0.0%	294,571	3/31/2022
2021 Q4	2/11/2022	34,967	0.0%	295,719	12/31/2021
2021 Q3	11/18/2021	40,103	0.0%	298,945	9/30/2021
2021 Q2	8/11/2021	42,599	0.0%	263,115	6/30/2021
2021 Q1	5/13/2021	16,287	0.0%	202,928	3/31/2021
2020 Q4	2/9/2021	11,135	0.0%	204,676	12/31/2020
2020 Q3	11/12/2020	3,737	0.0%	187,969	9/30/2020
2020 Q2	8/12/2020	3,923	0.0%	186,609	6/30/2020
2020 Q1	5/6/2020	2,115	0.0%	172,966	3/31/2020
2019 Q4	2/14/2020	3,286	0.0%	223,967	12/31/2019